Literature DB >> 18180160

Potent memapsin 2 (beta-secretase) inhibitors: design, synthesis, protein-ligand X-ray structure, and in vivo evaluation.

Arun K Ghosh1, Nagaswamy Kumaragurubaran, Lin Hong, Sarang Kulkarni, Xiaoming Xu, Heather B Miller, Dandepally Srinivasa Reddy, Vajira Weerasena, Robert Turner, Wanpin Chang, Gerald Koelsch, Jordan Tang.   

Abstract

Structure-based design, synthesis, and biological evaluation of a series of peptidomimetic beta-secretase inhibitors incorporating hydroxyethylamine isosteres are described. We have identified inhibitor 24 which has shown exceedingly potent activity in memapsin 2 enzyme inhibitory (K(i) 1.8 nM) and cellular (IC(50)=1 nM in Chinese hamster ovary cells) assays. Inhibitor 24 has also shown very impressive in vivo properties (up to 65% reduction of plasma A beta) in transgenic mice. The X-ray structure of protein-ligand complex of memapsin 2 revealed critical interactions in the memapsin 2 active site.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180160      PMCID: PMC2577816          DOI: 10.1016/j.bmcl.2007.12.028

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  23 in total

1.  Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor.

Authors:  L Hong; G Koelsch; X Lin; S Wu; S Terzyan; A K Ghosh; X C Zhang; J Tang
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

Review 2.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

3.  Amyloid-beta reduction by memapsin 2 (beta-secretase) immunization.

Authors:  Wan-Pin Chang; Deborah Downs; Xiang-Ping Huang; Huining Da; Kar-Ming Fung; Jordan Tang
Journal:  FASEB J       Date:  2007-05-10       Impact factor: 5.191

4.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

Authors:  R Vassar; B D Bennett; S Babu-Khan; S Kahn; E A Mendiaz; P Denis; D B Teplow; S Ross; P Amarante; R Loeloff; Y Luo; S Fisher; J Fuller; S Edenson; J Lile; M A Jarosinski; A L Biere; E Curran; T Burgess; J C Louis; F Collins; J Treanor; G Rogers; M Citron
Journal:  Science       Date:  1999-10-22       Impact factor: 47.728

5.  Structure-based design: potent inhibitors of human brain memapsin 2 (beta-secretase).

Authors:  A K Ghosh; G Bilcer; C Harwood; R Kawahama; D Shin; K A Hussain; L Hong; J A Loy; C Nguyen; G Koelsch; J Ermolieff; J Tang
Journal:  J Med Chem       Date:  2001-08-30       Impact factor: 7.446

6.  Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein.

Authors:  X Lin; G Koelsch; S Wu; D Downs; A Dashti; J Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

7.  Subsite specificity of memapsin 2 (beta-secretase): implications for inhibitor design.

Authors:  R T Turner; G Koelsch; L Hong; P Castanheira; J Ermolieff; A K Ghosh; J Tang; P Castenheira; A Ghosh
Journal:  Biochemistry       Date:  2001-08-28       Impact factor: 3.162

8.  Proteolytic activation of recombinant pro-memapsin 2 (pro-beta-secretase) studied with new fluorogenic substrates.

Authors:  J Ermolieff; J A Loy; G Koelsch; J Tang
Journal:  Biochemistry       Date:  2000-10-10       Impact factor: 3.162

9.  Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

Authors:  T Kawarabayashi; L H Younkin; T C Saido; M Shoji; K H Ashe; S G Younkin
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

10.  Specificity of memapsin 1 and its implications on the design of memapsin 2 (beta-secretase) inhibitor selectivity.

Authors:  Robert T Turner; Jeffrey A Loy; Chan Nguyen; Thippeswamy Devasamudram; Arun K Ghosh; Gerald Koelsch; Jordan Tang
Journal:  Biochemistry       Date:  2002-07-09       Impact factor: 3.162

View more
  27 in total

Review 1.  Inhibition of BACE1 for therapeutic use in Alzheimer's disease.

Authors:  Xiaoyang Luo; Riqiang Yan
Journal:  Int J Clin Exp Pathol       Date:  2010-07-08

Review 2.  Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.

Authors:  Meaghan C Creed; Norton W Milgram
Journal:  Age (Dordr)       Date:  2010-04-20

3.  Highly Selective and Potent Human β-Secretase 2 (BACE2) Inhibitors against Type 2 Diabetes: Design, Synthesis, X-ray Structure and Structure-Activity Relationship Studies.

Authors:  Arun K Ghosh; Margherita Brindisi; Yu-Chen Yen; Emma K Lendy; Satish Kovela; Emilio Leal Cárdenas; Bhavanam Sekhara Reddy; Kalapala Venketeswara Rao; Deborah Downs; Xiangping Huang; Jordan Tang; Andrew D Mesecar
Journal:  ChemMedChem       Date:  2019-02-05       Impact factor: 3.466

4.  Design, synthesis, and X-ray structural studies of BACE-1 inhibitors containing substituted 2-oxopiperazines as P1'-P2' ligands.

Authors:  Arun K Ghosh; Margherita Brindisi; Yu-Chen Yen; Emilio L Cárdenas; Jean-Rene Ella-Menye; Nagaswamy Kumaragurubaran; Xiangping Huang; Jordan Tang; Andrew D Mesecar
Journal:  Bioorg Med Chem Lett       Date:  2017-04-08       Impact factor: 2.823

5.  Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice.

Authors:  Wan-Pin Chang; Xiangping Huang; Deborah Downs; John R Cirrito; Gerald Koelsch; David M Holtzman; Arun K Ghosh; Jordan Tang
Journal:  FASEB J       Date:  2010-11-08       Impact factor: 5.191

6.  Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression.

Authors:  Latha Devi; Jordan Tang; Masuo Ohno
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

7.  Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex.

Authors:  Arun K Ghosh; Margherita Brindisi; Prasanth R Nyalapatla; Jun Takayama; Jean-Rene Ella-Menye; Sofiya Yashchuk; Johnson Agniswamy; Yuan-Fang Wang; Manabu Aoki; Masayuki Amano; Irene T Weber; Hiroaki Mitsuya
Journal:  Bioorg Med Chem       Date:  2017-04-09       Impact factor: 3.641

8.  Development of an Efficient Enzyme Production and Structure-Based Discovery Platform for BACE1 Inhibitors.

Authors:  Yu-Chen Yen; Annalissa M Kammeyer; Katherine C Jensen; Jagannadharao Tirlangi; Arun K Ghosh; Andrew D Mesecar
Journal:  Biochemistry       Date:  2019-10-22       Impact factor: 3.162

Review 9.  Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators.

Authors:  Francesco Panza; Vincenzo Solfrizzi; Vincenza Frisardi; Cristiano Capurso; Alessia D'Introno; Anna M Colacicco; Gianluigi Vendemiale; Antonio Capurso; Bruno P Imbimbo
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 10.  Harnessing nature's insight: design of aspartyl protease inhibitors from treatment of drug-resistant HIV to Alzheimer's disease.

Authors:  Arun K Ghosh
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.